Report Detail
Global Kidney (Renal) Fibrosis Market Insights, Forecast to 2025
- RnM2652447 |
- 17 April, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
The global Kidney (Renal) Fibrosis market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Kidney (Renal) Fibrosis market based on company, product type, end user and key regions.
This report studies the global market size of Kidney (Renal) Fibrosis in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Kidney (Renal) Fibrosis in these regions.
This research report categorizes the global Kidney (Renal) Fibrosis market by top players/brands, region, type and end user. This report also studies the global Kidney (Renal) Fibrosis market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
Pfizer
Roche
InterMune
Galectin Therapeutics
La Jolla Pharmaceutical Company
ProMetic Life-Sciences Inc.
BioLine Rx Ltd
Genzyme Corporation
Market size by Product
Angiotensin Converting enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Vasopeptidase Inhibitors
Market size by End User
Research Center
Hospital
Clinic
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Kidney (Renal) Fibrosis market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Kidney (Renal) Fibrosis market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Kidney (Renal) Fibrosis companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Kidney (Renal) Fibrosis submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Kidney (Renal) Fibrosis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Kidney (Renal) Fibrosis market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Kidney (Renal) Fibrosis Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Kidney (Renal) Fibrosis Market Size Growth Rate by Product
- 1.4.2 Angiotensin Converting enzyme (ACE) Inhibitors
- 1.4.3 Pirfenidone
- 1.4.4 Renin Inhibitors
- 1.4.5 Angiotensin II Receptor Blockers (ARBs)
- 1.4.6 Vasopeptidase Inhibitors
- 1.5 Market by End User
- 1.5.1 Global Kidney (Renal) Fibrosis Market Size Growth Rate by End User
- 1.5.2 Research Center
- 1.5.3 Hospital
- 1.5.4 Clinic
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Kidney (Renal) Fibrosis Market Size
- 2.1.1 Global Kidney (Renal) Fibrosis Revenue 2014-2025
- 2.1.2 Global Kidney (Renal) Fibrosis Sales 2014-2025
- 2.2 Kidney (Renal) Fibrosis Growth Rate by Regions
- 2.2.1 Global Kidney (Renal) Fibrosis Sales by Regions
- 2.2.2 Global Kidney (Renal) Fibrosis Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Kidney (Renal) Fibrosis Sales by Manufacturers
- 3.1.1 Kidney (Renal) Fibrosis Sales by Manufacturers
- 3.1.2 Kidney (Renal) Fibrosis Sales Market Share by Manufacturers
- 3.1.3 Global Kidney (Renal) Fibrosis Market Concentration Ratio (CR5 and HHI)
- 3.2 Kidney (Renal) Fibrosis Revenue by Manufacturers
- 3.2.1 Kidney (Renal) Fibrosis Revenue by Manufacturers (2014-2019)
- 3.2.2 Kidney (Renal) Fibrosis Revenue Share by Manufacturers (2014-2019)
- 3.3 Kidney (Renal) Fibrosis Price by Manufacturers
- 3.4 Kidney (Renal) Fibrosis Manufacturing Base Distribution, Product Types
- 3.4.1 Kidney (Renal) Fibrosis Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Kidney (Renal) Fibrosis Product Type
- 3.4.3 Date of International Manufacturers Enter into Kidney (Renal) Fibrosis Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Kidney (Renal) Fibrosis Sales by Product
- 4.2 Global Kidney (Renal) Fibrosis Revenue by Product
- 4.3 Kidney (Renal) Fibrosis Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Kidney (Renal) Fibrosis Breakdown Data by End User
6 North America
- 6.1 North America Kidney (Renal) Fibrosis by Countries
- 6.1.1 North America Kidney (Renal) Fibrosis Sales by Countries
- 6.1.2 North America Kidney (Renal) Fibrosis Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Kidney (Renal) Fibrosis by Product
- 6.3 North America Kidney (Renal) Fibrosis by End User
7 Europe
- 7.1 Europe Kidney (Renal) Fibrosis by Countries
- 7.1.1 Europe Kidney (Renal) Fibrosis Sales by Countries
- 7.1.2 Europe Kidney (Renal) Fibrosis Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Kidney (Renal) Fibrosis by Product
- 7.3 Europe Kidney (Renal) Fibrosis by End User
8 Asia Pacific
- 8.1 Asia Pacific Kidney (Renal) Fibrosis by Countries
- 8.1.1 Asia Pacific Kidney (Renal) Fibrosis Sales by Countries
- 8.1.2 Asia Pacific Kidney (Renal) Fibrosis Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Kidney (Renal) Fibrosis by Product
- 8.3 Asia Pacific Kidney (Renal) Fibrosis by End User
9 Central & South America
- 9.1 Central & South America Kidney (Renal) Fibrosis by Countries
- 9.1.1 Central & South America Kidney (Renal) Fibrosis Sales by Countries
- 9.1.2 Central & South America Kidney (Renal) Fibrosis Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Kidney (Renal) Fibrosis by Product
- 9.3 Central & South America Kidney (Renal) Fibrosis by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Kidney (Renal) Fibrosis by Countries
- 10.1.1 Middle East and Africa Kidney (Renal) Fibrosis Sales by Countries
- 10.1.2 Middle East and Africa Kidney (Renal) Fibrosis Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Kidney (Renal) Fibrosis by Product
- 10.3 Middle East and Africa Kidney (Renal) Fibrosis by End User
11 Company Profiles
- 11.1 Merck
- 11.1.1 Merck Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Merck Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Merck Kidney (Renal) Fibrosis Products Offered
- 11.1.5 Merck Recent Development
- 11.2 Pfizer
- 11.2.1 Pfizer Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Pfizer Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Pfizer Kidney (Renal) Fibrosis Products Offered
- 11.2.5 Pfizer Recent Development
- 11.3 Roche
- 11.3.1 Roche Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Roche Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Roche Kidney (Renal) Fibrosis Products Offered
- 11.3.5 Roche Recent Development
- 11.4 InterMune
- 11.4.1 InterMune Company Details
- 11.4.2 Company Business Overview
- 11.4.3 InterMune Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 InterMune Kidney (Renal) Fibrosis Products Offered
- 11.4.5 InterMune Recent Development
- 11.5 Galectin Therapeutics
- 11.5.1 Galectin Therapeutics Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Galectin Therapeutics Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Galectin Therapeutics Kidney (Renal) Fibrosis Products Offered
- 11.5.5 Galectin Therapeutics Recent Development
- 11.6 La Jolla Pharmaceutical Company
- 11.6.1 La Jolla Pharmaceutical Company Company Details
- 11.6.2 Company Business Overview
- 11.6.3 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Products Offered
- 11.6.5 La Jolla Pharmaceutical Company Recent Development
- 11.7 ProMetic Life-Sciences Inc.
- 11.7.1 ProMetic Life-Sciences Inc. Company Details
- 11.7.2 Company Business Overview
- 11.7.3 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Products Offered
- 11.7.5 ProMetic Life-Sciences Inc. Recent Development
- 11.8 BioLine Rx Ltd
- 11.8.1 BioLine Rx Ltd Company Details
- 11.8.2 Company Business Overview
- 11.8.3 BioLine Rx Ltd Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 BioLine Rx Ltd Kidney (Renal) Fibrosis Products Offered
- 11.8.5 BioLine Rx Ltd Recent Development
- 11.9 Genzyme Corporation
- 11.9.1 Genzyme Corporation Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Genzyme Corporation Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Genzyme Corporation Kidney (Renal) Fibrosis Products Offered
- 11.9.5 Genzyme Corporation Recent Development
12 Future Forecast
- 12.1 Kidney (Renal) Fibrosis Market Forecast by Regions
- 12.1.1 Global Kidney (Renal) Fibrosis Sales Forecast by Regions 2019-2025
- 12.1.2 Global Kidney (Renal) Fibrosis Revenue Forecast by Regions 2019-2025
- 12.2 Kidney (Renal) Fibrosis Market Forecast by Product
- 12.2.1 Global Kidney (Renal) Fibrosis Sales Forecast by Product 2019-2025
- 12.2.2 Global Kidney (Renal) Fibrosis Revenue Forecast by Product 2019-2025
- 12.3 Kidney (Renal) Fibrosis Market Forecast by End User
- 12.4 North America Kidney (Renal) Fibrosis Forecast
- 12.5 Europe Kidney (Renal) Fibrosis Forecast
- 12.6 Asia Pacific Kidney (Renal) Fibrosis Forecast
- 12.7 Central & South America Kidney (Renal) Fibrosis Forecast
- 12.8 Middle East and Africa Kidney (Renal) Fibrosis Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Kidney (Renal) Fibrosis Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Kidney (Renal) Fibrosis . Industry analysis & Market Report on Kidney (Renal) Fibrosis is a syndicated market report, published as Global Kidney (Renal) Fibrosis Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Kidney (Renal) Fibrosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
